New Onset Atrial Fibrillation clinical trials

Explore recruiting new onset atrial fibrillation clinical trials.

Recruiting new onset atrial fibrillation studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

New Onset Atrial Fibrillation trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Pharmacokinetics and pharmacodynamics of intravenous versus enteral amiodarone in critically ill patients with new-onset atrial fibrillation – a randomised controlled pilot trial

Denmark

Therapeutic use (Phase IV) EU CTIS Study details

Impact of beta blocker administration on outcome among patients undergoing transcatheter aortic valve replacement - B-TAVR

Austria, Germany

Therapeutic use (Phase IV) EU CTIS Study details

A phase II, multicenter, 1:1 randomized, double-blind, placebo-controlled, parallel-group study to evaluate the efficacy of bolus application of Cyclosporine A (CsA) or Placebo in patients with Takotsubo syndrome. (Cyclosporine In Takotsubo syndrome (CIT))

Germany

Therapeutic exploratory (Phase II) EU CTIS Study details

EASi-PROTKT™ - A Phase III double-blind, randomised, parallel-group superiority trial to evaluate efficacy and safety of the combined use of oral vicadrostat (BI 690517) and empagliflozin compared with placebo and empagliflozin in participants with type 2 diabetes, hypertension and established cardiovascular disease

Lithuania, Netherlands, Ireland, Romania, France, Hungary +17 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

SGLT2 INHIBITION FOR CARDIOVASCULAR ENDPOINT REDUCTION IN HYPERTENSION

Germany, Slovenia, Spain, Austria, Portugal, Italy

Therapeutic confirmatory (Phase III) EU CTIS Study details

Impact of Tight blood Glucose Control within normal fasting ranges with insulin titration prescribed by the Leuven algorithm in adult critically ill patients.

Belgium

Therapeutic confirmatory (Phase III) EU CTIS Study details

New Onset Atrial Fibrillation trials by city

New Onset Atrial Fibrillation in Toronto New Onset Atrial Fibrillation in Vancouver New Onset Atrial Fibrillation in Montreal New Onset Atrial Fibrillation in Calgary New Onset Atrial Fibrillation in Edmonton New Onset Atrial Fibrillation in Ottawa New Onset Atrial Fibrillation in Winnipeg New Onset Atrial Fibrillation in Quebec City New Onset Atrial Fibrillation in Hamilton New Onset Atrial Fibrillation in Kitchener New Onset Atrial Fibrillation in London New Onset Atrial Fibrillation in Halifax New Onset Atrial Fibrillation in New York New Onset Atrial Fibrillation in Los Angeles New Onset Atrial Fibrillation in Chicago New Onset Atrial Fibrillation in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease